ARTICLE | Company News
CytoTherapeutics, Genentech gene/cell therapy news
March 20, 2000 8:00 AM UTC
The companies agreed that CTII will be relieved of an obligation to redeem $3.1 million of its stock from DNA in a dispute related to a 1996 agreement concerning CTII's encapsulated cell technology re...